Compare · head to head
InspireMD vs Rigel Pharmaceuticals
Rigel Pharmaceuticals ranks higher overall — 360 rank 66 vs 25.
Rigel Pharmaceuticals leads on Value (68 vs 47) and Quality (66 vs 16). InspireMD leads on Sentiment (58 vs 40). The two are close on Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Biotechnology |
| Size | Small | Small |
| ISIN | US45779A8466 | US7665597024 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 25 | 66 |
| Value | 47 | 68 |
| Quality | 16 | 66 |
| Growth | 41 | 42 |
| Safety | 61 | NR |
| Sentiment | 58 | 40 |
| Quality details | ||
| Profitability | 14 | 82 |
| Cash Truth | 19 | NR |
InspireMD vs NateraInspireMD vs Lexicon PharmaceuticalsInspireMD vs Kestra Medical TechnologiesInspireMD vs SANUWAVE HealthAdd a third stock →
Full analyses: InspireMD · Rigel Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100